Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $403.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2019-11-12

  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-09-30 was $160.00K, a 384.85% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-06-30 was $114.00K, a 2180.00% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $129.00K, a 101.56% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2018-09-30 was $33.00K, a 67.33% decline year-over-year.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month
2019-09-30$160.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$274.00K
derived: sum of 2 quarters · filed 2019-11-12
$403.00K
10-Q · filed 2019-11-12
2019-06-30$114.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$243.00K
10-Q · filed 2019-08-07
2019-03-31$129.00K
10-Q · filed 2019-05-09
2018-09-30$33.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$38.00K
derived: sum of 2 quarters · filed 2018-11-07
$102.00K
10-Q · filed 2018-11-07
2018-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$69.00K
10-Q · filed 2018-08-09
2018-03-31$64.00K
10-Q · filed 2018-05-10
2017-09-30$101.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$101.00K
derived: sum of 2 quarters · filed 2017-11-09
$104.00K
10-Q · filed 2017-11-09
2017-07-01$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$3.00K
10-Q · filed 2017-08-10
2017-04-01$3.00K
10-Q · filed 2017-05-11
2016-10-01$502.00K
10-Q · filed 2016-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87